Torres Vedras, Portugal

Gonçalo J L Bernardes

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Alfama, Inc.. Active years: 2015-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gonçalo J L Bernardes. Retrieved from https://idiyas.com/inventor/gonçalo-j-l-bernardes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gonçalo J L Bernardes: Innovator in Ruthenium Compounds

Introduction

Gonçalo J L Bernardes is a notable inventor based in Torres Vedras, Portugal. He has made significant contributions to the field of chemistry, particularly in the development of novel ruthenium compounds. His work focuses on innovative solutions for treating various medical conditions.

Latest Patents

Gonçalo holds 2 patents related to ruthenium carbon monoxide releasing molecules. His latest patents provide novel ruthenium compounds of specific formulas, which have been found useful in the treatment of malaria infections. Additionally, these compounds may also be beneficial in treating inflammatory conditions, such as acute lung injury and acute respiratory distress syndrome, which can be associated with malaria infections.

Career Highlights

Gonçalo is currently associated with Alfama, Inc., where he continues to advance his research and development efforts. His innovative work has positioned him as a key figure in the field of medicinal chemistry.

Collaborations

He collaborates with talented coworkers, including Ana Pamplona and Maria M Mota, who contribute to his research endeavors.

Conclusion

Gonçalo J L Bernardes is a prominent inventor whose work in ruthenium compounds is paving the way for new treatments in medicine. His contributions are significant in addressing critical health issues, showcasing the impact of innovation in the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…